Mast Cell-mediated Neuroinflammation May Have a Role in Attention Deficit Hyperactivity Disorder (Review)

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2020 Aug 4

PMID 32742317

Citations 9

Authors

Yuchen Song

Manqi Lu

Haixia Yuan

Tianyi Chen

XinMin Han

Affiliations

Soon will be listed here.

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental and behavioral disorder with a serious negative impact on the quality of life from childhood until adulthood, which may cause academic failure, family disharmony and even social unrest. The pathogenesis of ADHD has remained to be fully elucidated, leading to difficulties in the treatment of this disease. Genetic and environmental factors contribute to the risk of ADHD development. Certain studies indicated that ADHD has high comorbidity with allergic and autoimmune diseases, with various patients with ADHD having a high inflammatory status. Increasing evidence indicated that mast cells (MCs) are involved in the pathogenesis of brain inflammation and neuropsychiatric disorders. MCs may cause or aggravate neuroinflammation via the selective release of inflammatory factors, interaction with glial cells and neurons, activation of the hypothalamic-pituitary adrenal axis or disruption of the blood-brain barrier integrity. In the present review, the notion that MC activation may be involved in the occurrence and development of ADHD through a number of ways is discussed based on previously published studies. The association between MCs and ADHD appears to lack sufficient evidence at present and this hypothesis is considered to be worthy of further study, providing a novel perspective for the treatment of ADHD.

Citing Articles

Pain-Associated Diagnoses in Childhood Before the Diagnosis of Attention-Deficit/Hyperactivity Disorder: A Population-Based Study.

Merzon E, Magen E, Levy Y, Ashkenazi S, Manor I, Weizman A Children (Basel). 2024; 11(11).

PMID: 39594963 PMC: 11593160. DOI: 10.3390/children11111388.

Rhynchophylline Alleviates Hyperactivity and Cognitive Flexibility Impairment Associated With Inhibition of Inflammatory Responses in Mice That Partly Lack the Dopamine Transporter Protein.

Li J, Chen B, Li Z, Wang Y, Alberts I, Sun K Brain Behav. 2024; 14(11):e70121.

PMID: 39529258 PMC: 11554589. DOI: 10.1002/brb3.70121.

Childhood neurodivergent traits, inflammation and chronic disabling fatigue in adolescence: a longitudinal case-control study.

Quadt L, Csecs J, Bond R, Harrison N, Critchley H, Davies K BMJ Open. 2024; 14(7):e084203.

PMID: 39038862 PMC: 11733788. DOI: 10.1136/bmjopen-2024-084203.

Interaction of Diamine Oxidase with Psychostimulant Drugs for ADHD Management.

Tobajas Y, Alemany-Fornes M, Samarra I, Romero-Gimenez J, Tintore M, Del Pino A J Clin Med. 2023; 12(14).

PMID: 37510782 PMC: 10380856. DOI: 10.3390/jcm12144666.

Associations between T cells and attention problems in the general pediatric population: The Generation R study.

Looman K, Cecil C, Grosserichter-Wagener C, Kiefte-de Jong J, van Zelm M, Moll H JCPP Adv. 2023; 1(3):e12038.

PMID: 37431441 PMC: 10242894. DOI: 10.1002/jcv2.12038.

References

Jayaraj R, Azimullah S, Beiram R, Jalal F, Rosenberg G . Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019; 16(1):142. PMC: 6617684. DOI: 10.1186/s12974-019-1516-2. View

Kozlowska A, Wojtacha P, Rowniak M, Kolenkiewicz M, Huang A . ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology (Berl). 2019; 236(10):2937-2958. PMC: 6820808. DOI: 10.1007/s00213-019-5180-0. View

Kempuraj D, Selvakumar G, Thangavel R, Ahmed M, Zaheer S, Raikwar S . Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis. Front Neurosci. 2018; 11:703. PMC: 5733004. DOI: 10.3389/fnins.2017.00703. View

Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M . Production and functions of IL-33 in the central nervous system. Brain Res. 2011; 1385:8-17. DOI: 10.1016/j.brainres.2011.02.045. View

Gasque P, Singhrao S, Neal J, Gotze O, Morgan B . Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol. 1997; 150(1):31-41. PMC: 1858516. View

Mattila O, Strbian D, Saksi J, Pikkarainen T, Rantanen V, Tatlisumak T . Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke. 2011; 42(12):3600-5. DOI: 10.1161/STROKEAHA.111.632224. View

Christy A, Walker M, Hessner M, Brown M . Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun. 2012; 42:50-61. DOI: 10.1016/j.jaut.2012.11.003. View

Anand D, Colpo G, Zeni G, Zeni C, Teixeira A . Attention-Deficit/Hyperactivity Disorder And Inflammation: What Does Current Knowledge Tell Us? A Systematic Review. Front Psychiatry. 2017; 8:228. PMC: 5684106. DOI: 10.3389/fpsyt.2017.00228. View

Theoharides T, Leeman S . Effect of IL-33 on de novo synthesized mediators from human mast cells. J Allergy Clin Immunol. 2018; 143(1):451. DOI: 10.1016/j.jaci.2018.09.014. View

10.

Li X, Chauhan A, Sheikh A, Patil S, Chauhan V, Li X . Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009; 207(1-2):111-6. PMC: 2770268. DOI: 10.1016/j.jneuroim.2008.12.002. View

11.

Zass L, Hart S, Seedat S, Hemmings S, Malan-Muller S . Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity. Psychiatr Genet. 2016; 27(1):1-16. DOI: 10.1097/YPG.0000000000000143. View

12.

Sismanopoulos N, Delivanis D, Alysandratos K, Angelidou A, Therianou A, Kalogeromitros D . Mast cells in allergic and inflammatory diseases. Curr Pharm Des. 2012; 18(16):2261-77. DOI: 10.2174/138161212800165997. View

13.

Gurkan K, Bilgic A, Turkoglu S, Kilic B, Aysev A, Uslu R . Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment. J Psychopharmacol. 2009; 24(12):1810-8. DOI: 10.1177/0269881109348172. View

14.

Wang X, Li C, Chen Y, Hao Y, Zhou W, Chen C . Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun. 2008; 371(2):283-8. DOI: 10.1016/j.bbrc.2008.04.055. View

15.

Wang L, Yu Y, Fu M, Yeh W, Hsu J, Yang Y . Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin. Sci Rep. 2018; 8(1):10229. PMC: 6035203. DOI: 10.1038/s41598-018-28702-5. View

16.

Zhang S, Dong H, Zhang X, Li N, Sun J, Qian Y . Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption. Behav Brain Res. 2015; 298(Pt B):158-66. DOI: 10.1016/j.bbr.2015.11.003. View

17.

Perkins D, Vogel S . Inflammation: Species-specific TLR signalling -- insight into human disease. Nat Rev Rheumatol. 2016; 12(4):198-200. PMC: 4955569. DOI: 10.1038/nrrheum.2016.36. View

18.

Pelsser L, Buitelaar J, Savelkoul H . ADHD as a (non) allergic hypersensitivity disorder: a hypothesis. Pediatr Allergy Immunol. 2008; 20(2):107-12. DOI: 10.1111/j.1399-3038.2008.00749.x. View

19.

Hendriksen E, van Bergeijk D, Oosting R, Redegeld F . Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev. 2017; 79:119-133. DOI: 10.1016/j.neubiorev.2017.05.001. View

20.

Thompson J, Waldie K, Wall C, Murphy R, Mitchell E . Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One. 2014; 9(9):e108210. PMC: 4177119. DOI: 10.1371/journal.pone.0108210. View